Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Clinical trial NCT01012973 · COMPLETED

Trial details

NCT number: NCT01012973
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Retinal Vein Occlusion

Start date: 2009-10-01
Primary completion: 2011-02-01
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.